Answers are grounded in this paper and cite their sources.
Objective: To evaluate the safety and efficacy of a urethral catheter designed to administer lidocaine to the urethra in reducing patient pain during catheter removal.Methods: This was a prospective, randomized study involving 20-59-year old men scheduled to undergo surgery under general anesthesia with urethral catheter removal within 24 hours postoperatively.The catheter was a modified Foley catheter (14F) with a temperature sensor, which was removed, in which two holes were created proximal to the balloon.The catheter was inserted into the bladder in the usual manner.The patients were divided into two groups: the lidocaine and control groups.In the lidocaine group, 5 ml of 4% lidocaine was administered through the holes created in the urethral catheter 10 minutes before catheter removal, and the urinary meatus was compressed with gauze or other material to minimize leakage of the drug solution.Nothing was administered in the control group.The catheter was removed and visual analog scale (VAS) scores of removal pain were assessed by a single evaluator and compared between the two groups.Results: Forty patients were evaluated.There were no significant differences in patient characteristics between the groups.VAS scores at the time of catheter removal were lower in the lidocaine group (median: 11) than in the control group (median: 39) (P<0.001,Mann-Whitney U test).No adverse events were seen in either group.Conclusion: Use of our modified urethral catheter facilitates local anesthetic administration into the urethra, reducing catheter removal pain.
No takes yet. Share an insight, caveat, or question.
Kubo et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: